3
Announcements
Trials
Browse
Landscape
Status
Completed
2
Sponsor Class
INDUSTRY
2
Study Type
Observational
2
Sponsor
Cancer Type
Breast
3
Plasma cell
2
Genitourinary
2
Sarcoma
1
Conditions
Prostatic Neoplasms
2
Multiple Myeloma
2
Breast Neoplasms
2
Patient Compliance
1
Osteolysis
1
Bone Neoplasms
1
Interventions
Bortezomib
20
Blood Specimen Collection
9
Surveys and Questionnaires
8
Lenalidomide
8
Dexamethasone
8
pomalidomide
6
daratumumab
6
Flow Cytometry
6
Immunoenzyme Techniques
5
Biopsy
5
plerixafor
4
idecabtagene vicleucel
4
carfilzomib
4
Standard of Care
4
Polymerase Chain Reaction
4
Amplified Fragment Length Polymorphism Analysis
4
Specimen Handling
3
Psychiatric Rehabilitation
3
Patient Reported Outcome Measures
3
Microarray Analysis
3
Melphalan
3
Magnetic Resonance Spectroscopy
3
Interviews as Topic
3
Drug Therapy
3
Data Collection
3
Cytogenetic Analysis
3
Chromatin Immunoprecipitation Sequencing
3
talquetamab
2
selinexor
2
belantamab mafodotin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Observational
×
Clodronic Acid
×
Plasma cell
×
Clear all
NCT01198457
2012-09-07
BONA
Bayer
Completed
147 enrolled
NCT00909142
2012-04-06
BICAM
Bayer
Completed
149 enrolled